Cargando…
Development and Validation of a Targeted ‘Liquid’ NGS Panel for Treatment Customization in Patients with Metastatic Colorectal Cancer
The detection of actionable mutations in tumor tissue is a prerequisite for treatment customization in patients with metastatic colorectal cancer (mCRC). Analysis of circulating tumor DNA (ctDNA) for the identification of such mutations in patients’ plasma is an attractive alternative to invasive ti...
Autores principales: | Kastrisiou, Myrto, Zarkavelis, George, Kougioumtzi, Anastasia, Sakaloglou, Prodromos, Kostoulas, Charilaos, Georgiou, Ioannis, Batistatou, Anna, Pentheroudakis, George, Magklara, Angeliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700616/ https://www.ncbi.nlm.nih.gov/pubmed/34943612 http://dx.doi.org/10.3390/diagnostics11122375 |
Ejemplares similares
-
Clinical Application of Next-Generation Sequencing as A Liquid Biopsy Technique in Advanced Colorectal Cancer: A Trick or A Treat?
por: Kastrisiou, Myrto, et al.
Publicado: (2019) -
Biological and Clinical Significance of Mosaicism in Human Preimplantation Embryos
por: Bouba, Ioanna, et al.
Publicado: (2021) -
Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literature
por: Kastrisiou, Myrto, et al.
Publicado: (2018) -
Unusual N Gene Dropout and Ct Value Shift in Commercial Multiplex PCR Assays Caused by Mutated SARS-CoV-2 Strain
por: Bozidis, Petros, et al.
Publicado: (2022) -
Deep Sequencing Reveals New Aspects of Progesterone Receptor Signaling in Breast Cancer Cells
por: Kougioumtzi, Anastasia, et al.
Publicado: (2014)